Immutep Limited (ASX:IMM): Is Breakeven Near?
Simply Wall St NewsImmutep Limited's (ASX:IMM): Immutep Limited, a biotechnology company, engages in the research, development, and commercialization of biological products. The AU$115m market-cap posted a loss in its most recent financial year of -AU$12.7m and a latest trailing-twelve-month loss of -AU$17.1m leading to an even wider gap between loss and breakeven. As path to profitability is the topic on IMM’s investors mind, I’ve decided to gauge market sentiment. I’ve put together a brief outline of industry Read the full story
https://
simplywall.st/news/apple-post/immutep-limited-asximm-is-breakeven-near/
ASX vs NASDAQ, page-45
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.020(7.02%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $1.171M | 3.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101067 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8068 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
